Solution Structure of a Prion Protein: Implications for Infectivity

  • He Liu (Departments of Pharmaceutical Chemistry) ;
  • Jones, Shauna-Farr (Departments of Pharmaceutical Chemistry) ;
  • Nikolai Ulyanov (Departments of Pharmaceutical Chemistry) ;
  • Manuel Llinas (Department of Molecular and Cell Biology, University of California, Berkeley) ;
  • Susan Marqusee (Department of Molecular and Cell Biology, University of California, Berkeley) ;
  • Fred E. Cohen (Departments of Pharmaceutical Chemistry, Medicine) ;
  • Stanley B. Prusiner (Neurology, Medicine, and Biochemistry & Biophysics) ;
  • Thomas L. James (Departments of Pharmaceutical Chemistry)
  • Published : 1998.12.01

Abstract

Prions cause neurodegenerative diseases in animals and humans. The scrapie prion protein (PrPSc) is the major-possibly only-component of the infectious prion and is generated from the cellular isoform (PrPC) by a conformational change. Limited proteolysis of PrPSc produces an polypeptide comprised primarily of residues 90 to 231, which retains infectivity. The three-dimensional structure of rPrP(90-231), a recombinant protein resembling PrPC with the Syrian hamster (SHa) sequence, was solved using multidimensional NMR. Low-resolution structures of rPrP(90-231), synthetic peptides up to 56 residues, a longer (29-231, full-length) protein with SHa sequence, and a short here further structure refinement of rPrP(90-231) and dynamic features of the protein. Consideration of these features in the context of published data suggests regions of conformational heterogeneity, structural elements involved in the PrPC\longrightarrowPrPSc transformation, and possible structural features related to a species barrier to transmission of prion diseases.

Keywords